Filing Details
- Accession Number:
- 0001213900-22-030210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-31 06:10:09
- Reporting Period:
- 2022-05-26
- Accepted Time:
- 2022-05-31 06:10:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711754 | Inmune Bio Inc. | INMB | Biological Products, (No Disgnostic Substances) (2836) | 475205835 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1767280 | Joseph Raymond Tesi | C/O Inmune Bio Inc. 225 Ne Mizner Blvd., Suite 640 Boca Raton, FL 33432 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-26 | 6,300 | $6.41 | 1,520,698 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the average purchase price at a range of between $6.37 and $6.43 per share.
Billionaire Hedge Funds
